Inflammation, Endothelial Dysfunction, and Platelet Dysregulation in Atrial Fibrillation with Chronic Kidney Disease:

Maria-Daniela Tanasescu1, Andrei-Mihnea Rosu2, Alexandru Minca1

  • 1Department of Semiology-Emergency University Hospital, Carol Davila University of Medicine and Pharmacy, 022328 Bucharest, Romania.

Insights

Patients with atrial fibrillation (AF) and chronic kidney disease (CKD) face high risks of stroke and bleeding. Current treatments inadequately address shared biological pathways, necessitating a biology-informed approach to anticoagulation.

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Biology

Background:

  • Atrial fibrillation (AF) and chronic kidney disease (CKD) commonly coexist, increasing risks of thromboembolic and bleeding events.
  • Current anticoagulation dosing based on creatinine clearance may not fully address the complex pathophysiology of thrombohemorrhagic instability in this population.

Purpose of the Study:

  • To review recent evidence on the bidirectional cardio-renal axis in AF and CKD.
  • To focus on shared pathophysiological mechanisms including inflammation, endothelial dysfunction, and platelet dysregulation.
  • To propose a shift towards a biology-informed anticoagulation strategy.

Main Methods:

  • A narrative review synthesizing mechanistic and translational evidence.
  • Structured literature search of PubMed/MEDLINE, Scopus, and Web of Science (2018-2026).
  • Manual review of key references and guidelines.

Main Results:

  • Shared mechanisms in AF and CKD include inflammatory cytokine activation, oxidative stress, glycocalyx degradation, and platelet dysfunction.
  • These factors create a disrupted vascular interface leading to both stroke and bleeding.
  • Renal trajectory and biomarkers indicate dynamic and heterogeneous risk in advanced CKD.

Conclusions:

  • Anticoagulation decisions in AF with CKD should move beyond static filtration models.
  • A biology-informed approach integrating renal dynamics, vascular phenotype, and clinical context is needed.
  • This approach aims to optimize the balance between thromboembolic protection and bleeding safety.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.3K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.4K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559